Medscape1d
A Case of Acute Ischemic Stroke: Optimizing Management with Penumbra and Vessel Imaging
Diagnosis: Acute ischemic stroke caused by distal left internal carotid artery occlusion, with salvageable penumbral tissue and a persistent large-vessel occlusion. B.H. Buck is a Fellow of the ...
Indian neuro scientist Dr Vijaya bags prestigious Paul Dudley White International Scholar Award
Dr P Vijaya attended the International Stroke Conference 2025 in Los Angeles, emphasizing the need for standardized stroke ...
Medscape2d
New Hope for Better Postthrombectomy With IA Tenecteplase
Early findings suggest that IA tenecteplase after successful thrombectomy is safe and improves functional outcomes over standard care in anterior circulation LVO stroke.
Science Daily6d
Clot-busting meds may be effective up to 24 hours after initial stroke symptoms
In a randomized clinical trial, giving the clot-busting medication alteplase up to 24 hours after stroke symptoms first appeared increased the odds of better recovery by 50% compared to those who ...
UC San Francisco2d
International Stroke Conference Features UCSF Experts
Stroke experts from UCSF Health presented new research and clinical findings at the annual the American Stroke Association’s International Stroke Conference (ISC25), the world’s premier meeting ...
Medindia4d
Combining Clot Removal With Clot-Buster Shot Could Improve Stroke Recovery
Injecting tenecteplase into the artery after clot removal helps improve recovery in stroke survivors by enhancing blood flow ...
Removing large brain artery clot, chased with clot-buster shot may improve stroke outcomes
Removing a blood clot from a large brain artery, then injecting the clot-dissolving drug tenecteplase into the artery ...
Healio4d
Imaging analysis software accurately detects subdural hematoma
A novel imaging analysis technique registered a high degree of sensitivity and specificity in identifying both presence and ...
Clot-busting drug alteplase shows promise for stroke treatment up to 24 hours after onset
The clot-dissolving medication, alteplase, improved stroke patients' recovery by more than 50% when given up to 24 hours after the beginning of an ischemic stroke, according to preliminary ...
DiaMedica Therapeutics to Present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference
DiaMedica Therapeutics Inc. (Nasdaq: DMAC), a clinical-stage biopharmaceutical company focused on developing novel treatments for severe ischemic diseases, announced today that the Company’s ...
News Medical on MSN5d
Tenecteplase injection after clot removal improves stroke recovery
Removing a blood clot from a large brain artery, then injecting the clot-dissolving drug tenecteplase into the artery resulted in stroke survivors being more likely to have better function 90 days ...
Despite “industry challenges,” national rating agencies maintain Ballad Health “A” ratings with “stable” outlook
Johnson City, Tennessee, Feb. 11, 2025 (GLOBE NEWSWIRE) -- Ballad Health announced today that, despite cited industry challenges for hospitals and health systems, the nation’s major ratings agencies ...